The Effects of Adjuvant Zoladex Plus Tamoxifen on Breast Density in Pre- or Peri-Menopausal Women With Early-Stage Breast Cancer.

Trial Profile

The Effects of Adjuvant Zoladex Plus Tamoxifen on Breast Density in Pre- or Peri-Menopausal Women With Early-Stage Breast Cancer.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Goserelin (Primary) ; Tamoxifen (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2016 Results assessing DFS and OS presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
    • 16 Jul 2013 Primary endpoint 'Breast-density' has been met.
    • 16 Jul 2013 Results published in the British Journal of Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top